I'm LongbridgeAI, I can summarize articles.Mirum Pharmaceuticals CEO Christopher Peetz executed options for 20,000 shares on August 10, 2026, at $2.94 per share, and subsequently sold all 20,000 shares at an average price of approximately $98.51–$100.14. This transaction resulted in a direct ownership reduction to 194,309 shares, with an additional 187,500 held indirectly via the Peetz Family Trust.
- CEO Mirum, Christopher Peetz, mengeksekusi opsi 20.000 saham pada 10 Agustus 2026 dengan harga USD 2,94 per saham. * Pada hari yang sama, ia menjual total 20.000 saham pada harga rata-rata sekitar USD 98,51–USD 100,14 per saham. * Kepemilikan saham langsungnya turun menjadi 194.309 saham; ia juga melaporkan 187.500 saham tidak langsung melalui Peetz Family Trust. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001614740-26-000012), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here